Sonnet BioTherapeutics Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SONN research report →
About the company
Sonnet BioTherapeutics Holdings, Inc. , a biotechnology company based in Princeton, New Jersey, operates in the clinical stage with a primary focus on oncology. The firm is dedicated to developing novel platforms for creating biologic medicines that can exhibit either singular or dual therapeutic mechanisms.
- CEO
- Raghu Rao
- IPO
- 2006
- Employees
- 13
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $8.43M
- P/E
- -0.53
- P/S
- 0.00
- P/B
- 0.48
- EV/EBITDA
- 1.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -462.39%
- ROIC
- -116.41%
- Revenue
- $1.00M · 5268.84%
- Net Income
- $-16,112,737 · -116.65%
- EPS
- $-3.95 · 65.20%
- Op Income
- $-15,844,115
- FCF YoY
- -49.02%
- 52W High
- $19.30
- 52W Low
- $1.08
- 50D MA
- $4.58
- 200D MA
- $3.04
- Beta
- 1.47
- Avg Volume
- 1.11M
Get TickerSpark's AI analysis on SONN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 2, 25 | Kenney Richard T | other | 163,760 |
| Dec 2, 25 | Kenney Richard T | other | 86,505 |
| Dec 2, 25 | Kenney Richard T | other | 16,891 |
| Dec 2, 25 | Kenney Richard T | other | 86,505 |
| Dec 2, 25 | Kenney Richard T | other | 200 |
| Dec 2, 25 | Kenney Richard T | sell | 69,614 |
| Dec 2, 25 | Kenney Richard T | sell | 9,374 |
| Dec 2, 25 | Kenney Richard T | sell | 320,000 |
| Dec 2, 25 | Kenney Richard T | sell | 163,760 |
| Dec 2, 25 | MCANDREW STEPHEN J | sell | 6,446 |
Our SONN coverage
Recent articles, reports, and earnings notes.
No research on SONN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SONN report →Similar companies
Peers in the same neighborhood.